Literature DB >> 24888915

Comparative study of placental α-microglobulin-1, insulin-like growth factor binding protein-1 and nitrazine test to diagnose premature rupture of membranes: a randomized controlled trial.

De-ku Liang1, Hong-bo Qi, Xin Luo, Xiao-qiu Xiao, Xiao-yan Jia.   

Abstract

AIM: The aim of this study was to compare the accuracy of placental α-microglobulin-1 (PAMG-1), insulin-like growth factor binding protein-1 (IGFBP-1) and nitrazine test to diagnose premature rupture of membranes.
MATERIAL AND METHODS: A total of 120 pregnant women between 11 and 42 weeks with signs/symptoms of membrane rupture were eligible for our study. These women were evaluated with the PAMG-1, IGFBP-1, and nitrazine tests.
RESULTS: In the 120 women, the sensitivity, specificity, positive predictive value, and negative predictive value of PAMG-1, IGFBP-1 and nitrazine test were 100%, 100%, 100%, and 100%, 93.33%, 98.89%, 96.55% and 97.80%, and 93.33%, 94.44%, 84.85%, and 97.7%, respectively. In a comparison of the PAMG-1 test and the nitrazine test, positive coincidence rate was 84.85%, negative coincidence rate was 97.70%, total coincidence rate was 94.17%, and kappa value was 0.85. In a comparison of the PAMG-1 test and the IGFBP-1 test, the positive coincidence rate, negative coincidence rate and total coincidence rate were 96.55%, 97.80%, and 97.50%, and kappa value was 0.93.
CONCLUSION: PAMG-1 assay was the most accurate method to diagnose premature rupture of membranes with the highest sensitivity, specificity, positive predictive value and negative predictive value.
© 2014 The Authors. Journal of Obstetrics and Gynaecology Research © 2014 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  insulin-like growth factor binding protein-1; nitrazine test; placental α-microglobulin-1; pregnancy; premature rupture of membranes

Mesh:

Substances:

Year:  2014        PMID: 24888915     DOI: 10.1111/jog.12381

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

Review 1.  Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.

Authors:  Catherine E Majors; Chelsey A Smith; Mary E Natoli; Kathryn A Kundrod; Rebecca Richards-Kortum
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

2.  Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes.

Authors:  George U Eleje; Euzebus C Ezugwu; Ifeanyichukwu U Ezebialu; Nnabuike O Ojiegbe; Richard O Egeonu; Chukwudi C Obiora; Chigozie G Okafor; Joseph I Ikechebelu; Ahizechukwu C Eke
Journal:  Int J Gynaecol Obstet       Date:  2018-11-20       Impact factor: 4.447

3.  Icaritin inhibits decidualization of endometrial stromal cells.

Authors:  Aiwen Le; Zhong Hai Wang; Xiao Yun Dai; Tian Hui Xiao; Rong Zhuo; Baozhen Zhang; Zhonglin Xiao; Xiujun Fan
Journal:  Exp Ther Med       Date:  2017-10-10       Impact factor: 2.447

4.  Maternal lead exposure and premature rupture of membranes: a birth cohort study in China.

Authors:  Sha Huang; Wei Xia; Xia Sheng; Lin Qiu; Bin Zhang; Tian Chen; Shunqing Xu; Yuanyuan Li
Journal:  BMJ Open       Date:  2018-07-23       Impact factor: 2.692

5.  Placental protein 14 as a potential biomarker for diagnosis of preterm premature rupture of membranes.

Authors:  Yanyun Wang; Haibo Luo; Guanglu Che; Yanqin Li; Jun Gao; Qiongli Yang; Bin Zhou; Linbo Gao; Tao Wang; Yujie Liang; Lin Zhang
Journal:  Mol Med Rep       Date:  2018-05-03       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.